Sector Gamma AS Acquires New Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Sector Gamma AS has acquired a new stake in HCA Healthcare, Inc. valued at approximately $3,065,000 by purchasing 8,000 shares in the second quarter.
• HCA Healthcare's stock has recently seen price target adjustments by analysts, with estimates ranging from $370.00 to $485.00, indicating a consensus price target of $437.19.
• During the last earnings report, HCA Healthcare exceeded analysts' expectations by reporting $6.96 earnings per share and $19.16 billion in revenue, raising its FY 2025 guidance.

Sector Gamma AS bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 8,000 shares of the company's stock, valued at approximately $3,065,000.

A number of other institutional investors also recently bought and sold shares of HCA. ORG Partners LLC grew its stake in shares of HCA Healthcare by 27.9% during the 2nd quarter. ORG Partners LLC now owns 142 shares of the company's stock valued at $55,000 after purchasing an additional 31 shares during the period. Avantax Advisory Services Inc. grew its position in HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after buying an additional 32 shares during the period. Glenview Trust co raised its position in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company's stock worth $501,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC grew its position in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after acquiring an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its holdings in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after purchasing an additional 33 shares during the period. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently commented on HCA. Robert W. Baird raised their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Jefferies Financial Group upped their target price on shares of HCA Healthcare from $400.00 to $485.00 in a report on Wednesday, October 15th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $375.00 to $412.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 7th. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of HCA Healthcare in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $437.19.

HCA Healthcare Trading Down 0.3%

Shares of HCA Healthcare stock opened at $440.07 on Friday. The firm has a market cap of $102.97 billion, a PE ratio of 18.50, a PEG ratio of 1.39 and a beta of 1.40. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $447.09. The stock has a 50 day moving average of $413.82 and a 200 day moving average of $380.88.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.